Trends in Pharmaceutical Sciences and Technologies

Trends in Pharmaceutical Sciences and Technologies

Evaluation of possible preventive activity of Elaeagnus angustifolia L. against osteoporosis, an in vivo study

Document Type : Research(Original) Article

Authors
Farid Niknam
Amir Azadi
Pouya Faridi
Nader Tanideh
Mohammad M. Zarshenas
Department of Phytopharmaceuticals (Traditional Pharmacy), School of Pharmacy and Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract
Evaluation of possible preventive activity of Elaeagnus angustifolia L. against osteoporosis, an in vivo study
  1. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993 Jun;94(6):646-50. PubMed PMID: 8506892. Epub 1993/06/01. eng.
  2. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organization technical report series. 1994;843:1-129. PubMed PMID: 7941614. Epub 1994/01/01. eng.
  3. Organization WH. Guidelines for preclinical evaluation and clinical trials in osteoporosis. 1998.
  4. Gullberg B, Johnell O, Kanis J. World-wide projections for hip fracture. Osteoporosis international. 1997;7(5):407-13.
  5. Shepherd AJ. An overview of osteoporosis. Alternative therapies in health and medicine. 2004;10(2):26.
  6. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. New England journal of medicine. 1992;327(23):1637-42.
  7. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. New England Journal of Medicine. 1997;337(10):670-6.
  8. IH N. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference. South Med J. 2001;94:569-73.
  9. Liu J-m, Ning G, Chen J-l. Osteoporotic fractures in Asia: risk factors and strategies for prevention. Journal of bone and mineral metabolism. 2007;25(1):1-5.
  10. Larijani B, Resch H, Bonjour J, Meybodi HA, Tehrani MM. Osteoporosis in Iran, overview and management. Iranian Journal of Public Health. 2007:1-13.
  11. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI. JAMA. 1996 Nov 6;276(17):1389-96. PubMed PMID: 8892713. Epub 1996/11/06. eng.
  12. Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R. Anabolic Actions of Parathyroid Hormone on Bone*. Endocrine reviews. 1993;14(6):690-709.
  13. Chesnut CH, Silverman S, Andriano K, Genant H, Gimona A, Harris S, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. The American journal of medicine. 2000;109(4):267-76.
  14. Shirwaikar A, Khan S. Medicinal plants for the management of post menopausal osteoporosis: A review. The Open Bone Journal. 2010;2:1-13.
  15. Zarshenas MM, Petramfar P, Firoozabadi A, Moein MR, Mohagheghzadeh A. Types of headache and those remedies in traditional persian medicine. Pharmacognosy reviews. 2013 Jan;7(13):17-26. PubMed PMID: 23922452. Pubmed Central PMCID: PMC3731875. Epub 2013/08/08. eng.
  16. Shirazi A. Makhzan al-adviyah (The Storehouse of Medicaments). Tehran: Tehran University of Medical Sciences. 2009.
  17. Naghibi F, Esmaeili S, Malekmohammadi M, Hassanpour A, Mosaddegh M. Ethnobotanical survey of medicinal plants used traditionally in two villages of Hamedan, Iran. Research Journal of Pharmacognosy (RJP). 2014;1(3):7-14.
  18. Niknam F, Azadi A, Barzegar A, Tanideh N, Faridi P, Zarshenas M. Phytochemistry and Phytotherapeutic Aspects of Elaeagnus angustifolia L. Current drug discovery technologies. 2016.
  19. Farzaei MH, Bahramsoltani R, Abbasabadi Z, Rahimi R. A comprehensive review on phytochemical and pharmacological aspects of Elaeagnus angustifolia L. Journal of Pharmacy and Pharmacology. 2015;67(11):1467-80.
  20. Reginster J-YL. Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosis. Bone and mineral. 1993;23(3):223-32.
  21. Horcajada‐Molteni MN, Crespy V, Coxam V, Davicco MJ, Remesy C, Barlet JP. Rutin inhibits ovariectomy‐induced osteopenia in rats. Journal of Bone and Mineral Research. 2000;15(11):2251-8.
  22. Ma H, Jia Z, Ge X, He X, Chen K, Bai M. Studies on the theraputic effect of total flavonoids of Herba Epimedii on experimental osteoporosis in rats. West China Journal of Pharmaceutical Sciences. 2001;17(3):163-7.
  23. Abizov E, Tolkachev O, Mal’tsev S, Abizova E. Composition of biologically active substances isolated from the fruits of Russian olive (Elaeagnus angustifolia) introduced in the European part of Russia. Pharmaceutical chemistry journal. 2008;42(12):696-8.
  24. Bendaikha S, Gadaut M, Harakat D, Magid A. Acylated flavonol glycosides from the flower of Elaeagnus angustifolia L. Phytochemistry. 2014;103:129-36.
  25. Wang Y., Guo T., Li J., Zhou S., Zhao P. Four flavonoid glycosides from the pulps of Elaeagnus angustifolia and their antioxidant activities. Advanced Materials Research. 2012;756:66-20.
  26. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr. 1996 Jan;126(1):161-7. PubMed PMID: 8558297. Epub 1996/01/01. eng.
  27. Hassan NM, Hassan RA, Setta LA, El-moniem MA, Ahmed HH, Hammouda FM. Potent role of dietary phytoestrogen plants cultivated in Egypt against osteoporosis in ovariectomized rats. Australian Journal of Basic and Applied Sciences. 2010;4(2):359-69.
  28. Rangrez AY, Balakrishnan S, Parikh PH. Osteoprotective effect three anti inflammatory plants in ovariectomized wistar rats. Pharmacologyonline. 2011;1:675-84.
  29. Gupta R, Singh M, Kumar M, Kumar S, Singh SP. Anti-osteoporotic effect of Urtica dioica on ovariectomised rat. Indian Journal of Research in Pharmacy and Biotechnology. 2014;2(1):1015.
Trends in Pharmaceutical Sciences and Technologies
Volume 2, Issue 4 - Serial Number 4
10
December 2016
Pages 291-296